Home › Funds › Frazier Life Sciences Management, L.P. › ATOS

Frazier Life Sciences Management, L.P. position in ATOS

ATOSSA THERAPEUTICS INC · Health Care

Frazier Life Sciences Management, L.P. reported holding 7,046,271 shares of ATOS (ATOSSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$120.8M, representing 3.08% of its reported portfolio and ranking #10 among its reported holdings. Frazier Life Sciences Management, L.P. first reported this position in Q3 2026.

Latest position (Q3 2026)7.05M sh
Reported value held$120.77M
Portfolio Weight3.08%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s ATOS position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in ATOS in Q3 2026 at 7,046,271 shares (US$120.8M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 7.05M $120.77M New

About ATOS and 13F data

ATOS (ATOSSA THERAPEUTICS INC) is a Health Care company. 62 other funds we track also report a position in ATOS — the largest reported positions include venBio Partners LLC (US$71.7M), Deep Track Capital, LP (US$55.0M), EcoR1 Capital, LLC (US$34.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ATOS

All ATOS fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held ATOS?

Frazier Life Sciences Management, L.P. has disclosed ATOS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Frazier Life Sciences Management, L.P.'s current position in ATOS?

As of Q3 2026, Frazier Life Sciences Management, L.P. holds 7.05M shares of ATOS (ATOSSA THERAPEUTICS INC), valued at $120.77M, representing 3.08% of its reported portfolio and ranking #10.

Has Frazier Life Sciences Management, L.P. been buying or selling ATOS?

In the latest 13F filing (Q3 2026), Frazier Life Sciences Management, L.P. newly opened its position in ATOS.

Which other funds hold ATOS?

Other major institutional holders of ATOS include venBio Partners LLC, Deep Track Capital, LP, EcoR1 Capital, LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.